BioTech Stocks with FDA drugs under .50
1 ACEL Tamir Biotechnology, Inc.
2 MRNA Marina Biotech, Inc.
3 ALSE Alseres Pharmaceuticals, Inc.
4 HEB Hemispherx Biopharma, Inc. MarketCap= $26 Mil
ALFERON N Injection® [Interferon alfa-n3 (human leukocyte derived)] is the Company's registered trademark for its injectable formulation of Natural Alpha Interferon, approved by the U.S. Food and Drug Administration (FDA) for the intralesional treatment of refractory or recurring external condylomata acuminata in patients 18 years of age or older.
5 BNVI Bionovo, Inc.
6 CAPS Capstone Therapeutics Corp.
7 POLXF Polydex Pharmaceuticals Ltd.
8 SNT Senesco Technologies Inc.
9 CYTR CytRx Corporation
10 CRMD CorMedix, Inc.
11 CVM CEL-SCI Corp.
12 CXM Cardium Therapeutics Inc.
13 RNN Rexahn Pharmaceuticals, Inc.
14 GALE Galena Biopharma, Inc.
15 INO Inovio Pharmaceuticals, Inc.
16 TNGN Tengion, Inc.
Of these companies, only 1 has 1 fda approved drug. It has a market cap of $26 mil, half that of BPAX currently well over $50 mil
So which way is BPAX headed, only up from here. How long will it take, nobody knows.
What are your thoughts?
